These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 8287485

  • 1. Immobilized anti-TCR mAb induces split functions in a CD8+ CTL clone.
    Kuwano K, Ono S, Arai S.
    Cell Immunol; 1994 Jan; 153(1):105-16. PubMed ID: 8287485
    [Abstract] [Full Text] [Related]

  • 2. An anergic cytotoxic T lymphocyte clone exhibits granule exocytosis-mediated cytotoxicity.
    Kuwano K, Akashi A, Arai S.
    Cell Immunol; 1998 May 01; 185(2):114-22. PubMed ID: 9636689
    [Abstract] [Full Text] [Related]

  • 3. Functionally anergic lpr and gld B220+ T cell receptor (TCR)-alpha/beta+ double-negative T cells express CD28 and respond to costimulation with phorbol myristate acetate and antibodies to CD28 and the TCR.
    Giese T, Allison JP, Davidson WF.
    J Immunol; 1993 Jul 15; 151(2):597-609. PubMed ID: 7687618
    [Abstract] [Full Text] [Related]

  • 4. The requirements for triggering of lysis by cytolytic T lymphocyte clones. II. Cyclosporin A inhibits TCR-mediated exocytosis by only selectively inhibits TCR-mediated lytic activity by cloned CTL.
    Lancki DW, Kaper BP, Fitch FW.
    J Immunol; 1989 Jan 15; 142(2):416-24. PubMed ID: 2492047
    [Abstract] [Full Text] [Related]

  • 5. TCR alpha beta+ anti-tumor cytolytic T lymphocytes express NKR-P1 whilethe anti-tumor activity of TCR gamma delta+ T lymphocytes is not correlated to NKR-P1 expression.
    Yrlid U, Petersson E, Dohlsten M, Hedlund G.
    Cell Immunol; 1996 Nov 01; 173(2):287-94. PubMed ID: 8912889
    [Abstract] [Full Text] [Related]

  • 6. Rejection of an IA+ variant line of FBL-3 leukemia by cytotoxic T lymphocytes with CD4+ and CD4-CD8- T cell receptor-alpha beta phenotypes generated in CD8-depleted C57BL/6 mice.
    Yoshimura A, Shiku H, Nakayama E.
    J Immunol; 1993 Jun 01; 150(11):4900-10. PubMed ID: 8496592
    [Abstract] [Full Text] [Related]

  • 7. Antibodies to the L3T4 and Lyt-2 molecules interfere with antigen receptor-driven activation of cloned murine T cells.
    Moldwin RL, Havran WL, Nau GJ, Lancki DW, Kim DK, Fitch FW.
    J Immunol; 1987 Aug 01; 139(3):657-64. PubMed ID: 2955046
    [Abstract] [Full Text] [Related]

  • 8. Opposite CD4/CD8 lineage decisions of CD4+8+ mouse and rat thymocytes to equivalent triggering signals: correlation with thymic expression of a truncated CD8 alpha chain in mice but not rats.
    Mitnacht R, Bischof A, Torres-Nagel N, Hünig T.
    J Immunol; 1998 Jan 15; 160(2):700-7. PubMed ID: 9551905
    [Abstract] [Full Text] [Related]

  • 9. Establishment of T-cell lines from infiltrated NOD islets by stimulation of specific T-cell receptor V beta segments.
    Maugendre D, Legrand B, Olivi M, Bedossa P, Bach JF, Carnaud C.
    J Autoimmun; 1993 Aug 15; 6(4):423-36. PubMed ID: 8105789
    [Abstract] [Full Text] [Related]

  • 10. Accessory molecules involved in antigen-mediated cytolysis and lymphokine production by cytotoxic T lymphocyte subsets. I. Identification of functions for the T cell surface molecules Ly-6C and Thy-1.
    Johnson R, Lancki DW, Fitch FW.
    J Immunol; 1993 Sep 15; 151(6):2986-99. PubMed ID: 8104217
    [Abstract] [Full Text] [Related]

  • 11. Signals for activation of CD8-dependent adhesion and costimulation in CTLs.
    O'Rourke AM, Mescher MF.
    J Immunol; 1994 May 01; 152(9):4358-67. PubMed ID: 8157959
    [Abstract] [Full Text] [Related]

  • 12. Generation of IL-2-dependent cytolytic T lymphocytes (CTLs) with altered TCR responses derived from antigen-dependent CTL clones.
    Gullo CA, Esser MT, Fuller CL, Lam Braciale V.
    J Immunol; 1999 Jun 01; 162(11):6466-72. PubMed ID: 10352261
    [Abstract] [Full Text] [Related]

  • 13. Activated alpha beta-CD8+, but not alpha alpha-CD8+, TCR-alpha beta+ murine intestinal intraepithelial lymphocytes can mediate perforin-based cytotoxicity, whereas both subsets are active in Fas-based cytotoxicity.
    Gelfanov V, Gelfanova V, Lai YG, Liao NS.
    J Immunol; 1996 Jan 01; 156(1):35-41. PubMed ID: 8598484
    [Abstract] [Full Text] [Related]

  • 14. Class I- and class II-reactive TCRs coexpressed on CD4+ T cells both trigger CD4/CD8-shared and CD4-unique functions.
    Asnagli H, Schmitt-Verhulst AM, Guimezanes A.
    J Immunol; 1997 May 15; 158(10):4533-42. PubMed ID: 9144464
    [Abstract] [Full Text] [Related]

  • 15. Heterologous cross-linking of Lyt-2 (CD8) to the alpha beta-T cell receptor is more effective in T cell activation than homologous alpha beta-T cell receptor cross-linking.
    Boyce NW, Jönsson JI, Emmrich F, Eichmann K.
    J Immunol; 1988 Nov 01; 141(9):2882-8. PubMed ID: 3262671
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of IL 2-driven proliferation of murine T lymphocyte clones by supraoptimal levels of immobilized anti-T cell receptor monoclonal antibody.
    Nau GJ, Moldwin RL, Lancki DW, Kim DK, Fitch FW.
    J Immunol; 1987 Jul 01; 139(1):114-22. PubMed ID: 2953809
    [Abstract] [Full Text] [Related]

  • 17. The immunologic function of 1B2+ double negative (CD4-CD8-) T cells in the 2C transgenic mouse.
    Margenthaler JA, Flye MW.
    J Surg Res; 2005 Jun 15; 126(2):160-6. PubMed ID: 15919414
    [Abstract] [Full Text] [Related]

  • 18. Modulation of cytolytic T lymphocyte functions by an inhibitor of serine/threonine phosphatase, okadaic acid. Enhancement of cytolytic T lymphocyte-mediated cytotoxicity.
    Taffs RE, Redegeld FA, Sitkovsky MV.
    J Immunol; 1991 Jul 15; 147(2):722-8. PubMed ID: 1649222
    [Abstract] [Full Text] [Related]

  • 19. Involvement of two distinct killing mechanisms in bystander target cell lysis induced by a cytotoxic T lymphocyte clone.
    Kuwano K, Arai S.
    Cell Immunol; 1996 May 01; 169(2):288-93. PubMed ID: 8620557
    [Abstract] [Full Text] [Related]

  • 20. NK 1+ CD4- CD8- alphabeta T cells in the peritoneal cavity: specific T cell receptor-mediated cytotoxicity and selective IFN-gamma production against B cell leukemia and myeloma cells.
    Sugie T, Kubota H, Sato M, Nakamura E, Imamura M, Minato N.
    J Immunol; 1996 Nov 01; 157(9):3925-35. PubMed ID: 8892624
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.